Contract W81K0022P0048
Wells Pharma Of Houston Llc · Department Of Defense · June 24, 2024
Wells Pharma Of Houston Llc was awarded a federal contract by Department Of Defense (Department Of The Army) on June 24, 2024 for $908,000 (current value) of work in pharmaceutical preparation manufacturing. Performance is in Jbsa Ft Sam Houston, TX. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 5, 2024. If all options are exercised, the contract could reach $908,000.
Contract details
- PIID
- W81K0022P0048
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Jbsa Ft Sam Houston, TX
- First action
- June 24, 2024
- Latest action
- September 5, 2024
Description
NOREPINEPHRINE
Modification timeline
-
September 5, 2024Mod P00010 · Funding Only Action$676.9K
-
June 24, 2024Mod P00009 · Funding Only Action$393.5K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $51 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $91 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $32 |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $1.1K |
| Cardinal Health, Inc. | Department Of Defense | January 1, 2026 | $22 |
| Cardinal Health, Inc. | Department Of Defense | December 31, 2025 | $23 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81K0022P0048?
Contract W81K0022P0048 is a federal contract awarded to Wells Pharma Of Houston Llc by Department Of Defense on June 24, 2024 for $908,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract W81K0022P0048?
Wells Pharma Of Houston Llc won contract W81K0022P0048 from Department Of Defense.
How much is contract W81K0022P0048 worth?
Contract W81K0022P0048 has obligated $0 to date but carries a potential ceiling of $908,000 if fully funded and all options are exercised.